Press Releases

Date Title
February 5, 2020 Sharing clinical laboratory experience at SMFM 2020
We will present results from clinical laboratory experience that indicate noninvasive prenatal testing (NIPT) performs well for predicting aneuploidies in twin pregnancies. SAN DIEGO – February 5, 2020  – Progenity, developing precision medicine solutions across genomic/epigenomic, proteomic, and
January 8, 2020 Progenity Featured in Gastroenterology & Endoscopy News
Highlighting our work to improve the diagnosis and management of patients with small intestinal bacterial overgrowth (SIBO). Progenity was featured in  Gastroenterology & Endoscopy News  for our work on a capsule that improves the diagnosis and management of patients with small intestinal bacterial
December 10, 2019 Progenity and Geisinger Publish First Study of Primary, Case-Based Data on Economic Burden of Preeclampsia
SAN DIEGO and DANVILLE, Pa.  – December 10, 2019 – Progenity, a privately held biotechnology company, and  Geisinger , one of the nation’s most innovative health services organizations, announced publication of a study in  Obstetrics & Gynecology  demonstrating the significant economic burden
November 19, 2019 Progenity to Present at Piper Jaffray 31st Annual Healthcare Conference
SAN DIEGO, November 19, 2019  – Progenity, Inc. announced today that we'll be participating in the Piper Jaffray 31st Annual Healthcare Conference in New York, December 3 – 5. Progenity’s chief executive officer, Harry Stylli, PhD, will present a corporate overview on Wednesday, December 4, from
October 29, 2019 Progenity Presents Data at ACG 2019
Highlighting Opportunities for Technologies Aimed at Improving Diagnosis and Treatment of Gastrointestinal Disorders SAN DIEGO, October 29, 2019  – Progenity, Inc., a privately held biotechnology company, presented three posters this week at the 2019 American College of Gastroenterology Annual
October 22, 2019 Progenity Strengthens Executive Leadership Team with Appointment of Sami Shihabi as Chief Commercial Officer
SAN DIEGO, October 22, 2019  – Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, announced the promotion of Sami Shihabi to chief commercial officer.
September 18, 2019 Progenity Acquires Medimetrics Assets and Strengthens Global Leadership Position for Ingestible Device Technologies
This acquisition further strengthens Progenity’s existing intellectual property portfolio and development of ingestible devices designed to advance research, diagnosis, and treatment for conditions of the gastrointestinal (GI) tract. SAN DIEGO, September 18, 2019  – Progenity, Inc., a privately
August 7, 2019 Progenity Announces Appointment of Brian Kotzin, M.D., to its Board of Directors
Dr. Kotzin’s experience in the development of novel biotherapeutics, especially in autoimmune and inflammatory diseases, will provide valuable guidance as the company advances its pipeline of precision therapeutics/biotherapeutics and diagnostics. SAN DIEGO, August 7, 2019  – Progenity, Inc., a
June 25, 2019 NYU Winthrop and Progenity Collaborate to Develop Diagnostic Test to Assess Risk for Preterm Birth
Announcing a collaborative research and development initiative for women’s health with a focus on preterm births. Mineola, NY and San Diego, CA  – NYU Winthrop Hospital and Progenity, Inc., today announced a collaborative research and development initiative for women’s health with a focus on
June 11, 2019 Progenity to Present at Raymond James Life Sciences and MedTech Conference
Participating in New York, June 18 and 19. SAN DIEGO, June 11, 2019  – We will be participating in the Raymond James Life Sciences and MedTech Conference in New York, June 18 and 19. Chief Executive Officer Harry Stylli, Ph.D., will present a corporate overview on Wednesday, June 19, from 10:55 AM
Displaying 41 - 50 of 60